Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RNXT

RNXT - RenovoRx, Inc. Stock Price, Fair Value and News

$0.84+0.03 (+3.70%)
Market Closed

Price Targets

RNXT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RNXT Price Action

Last 7 days

6.3%

Last 30 days

-13.4%

Last 90 days

-12.5%

Trailing 12 Months

-17.6%

RNXT RSI Chart

RNXT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RNXT Valuation

Market Cap

30.8M

Price/Earnings (Trailing)

-2.77

Price/Sales (Trailing)

835.28

Price/Free Cashflow

-3.46

RNXT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

RNXT Fundamentals

RNXT Revenue

Revenue (TTM)

43.0K

Rev. Growth (Qtr)

-36.97%

RNXT Earnings

Earnings (TTM)

-11.1M

Earnings Growth (Yr)

-17.85%

Earnings Growth (Qtr)

-0.59%

RNXT Profitability

Operating Margin

-595.35%

Return on Equity

-137.47%

Return on Assets

-99.1%

Free Cashflow Yield

-28.94%

RNXT Investor Care

Shares Dilution (1Y)

52.70%

Diluted EPS (TTM)

-0.36

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
202400043.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About RenovoRx, Inc.

RNXT
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. The company was founded in 2009 and is headquartered in Los Altos, California.
 CEO
 WEBSITEhttps://renovorx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES10

RenovoRx, Inc. Frequently Asked Questions

RNXT is the stock ticker symbol of RenovoRx, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of RenovoRx, Inc. is 30.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, RNXT's PE ratio (Price to Earnings) is -2.77 and Price to Sales (PS) ratio is 835.28. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RNXT PE ratio will change depending on the future growth rate expectations of investors.